Inavolisib-based therapy in PIK3CA-mutated advanced breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 5
- By:
- Publication type:
- Article
Works matching IS 11794976 AND DT 2024
Results: 44
1
2
The experience of women receiving mastectomy care in an acute surgical ward: A qualitative study.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 5
- By:
- Publication type:
- Article
3
Analysis of HER2-low breast cancer in Aotearoa New Zealand: A nationwide retrospective cohort study.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 5
- By:
- Publication type:
- Article
4
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: Long-term survival analysis of the DESTINY-Breast03 trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 4
- By:
- Publication type:
- Article
5
Long-term outcomes of adjuvant trastuzumab for 9 weeks or 1 year for ERBB2-positive breast cancer: A secondary analysis of the SOLD randomized clinical trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 4
- By:
- Publication type:
- Article
6
Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 3
- By:
- Publication type:
- Article
7
Breast Cancer Index in premenopausal women with earlystage hormone receptor-positive breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 3
- By:
- Publication type:
- Article
8
Outcomes from low-risk ductal carcinoma in situ: A systematic review and meta-analysis.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 2
- By:
- Publication type:
- Article
9
Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: A pooled analysis of 155 746 women in 151 trials.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 2
- By:
- Publication type:
- Article
10
Cognition and return to work status 2 years after breast cancer diagnosis.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 1
- By:
- Publication type:
- Article
11
Welcome to Issue 45 of Breast Cancer Research Review.
- Published in:
- Breast Cancer Research Review, 2024, n. 45, p. 1
- By:
- Publication type:
- Article
12
Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2- negative breast cancer treated as triplenegative breast cancer: A Swedish populationbased cohort study.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 5
- By:
- Publication type:
- Article
13
Ribociclib-induced cutaneous adverse events in metastatic HR+/HER2- breast cancer: Incidence, multidisciplinary management, and prognostic implication.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 5
- By:
- Publication type:
- Article
14
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 5
- By:
- Publication type:
- Article
15
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: A randomized, controlled, phase II study.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 4
- By:
- Publication type:
- Article
16
3-year invasive disease-free survival with chemotherapy de-escalation using an <sup>18</sup>F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain).
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 4
- By:
- Publication type:
- Article
17
Breast-conserving therapy versus postmastectomy breast reconstruction: Propensity score-matched analysis.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 4
- By:
- Publication type:
- Article
18
Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: The Breast Cancer Etiology in Minorities study.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 2
- By:
- Publication type:
- Article
19
Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 2
- By:
- Publication type:
- Article
20
Denosumab prevents bone loss and microarchitectural deterioration in premenopausal women with breast cancer receiving estradiol suppression therapy: A randomized controlled trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 2
- By:
- Publication type:
- Article
21
Welcometo Issue 44 of Breast Cancer Research Review.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 1
- By:
- Publication type:
- Article
22
Behavioral interventions to improve breast cancer screening outreach: Two randomized clinical trials.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 1
- By:
- Publication type:
- Article
23
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 5
- By:
- Publication type:
- Article
24
Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: Which factors contribute?
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 5
- By:
- Publication type:
- Article
25
Nurse-led individualized follow-up versus regular physician-led visits after early breast cancer (MyHealth): A phase III randomized, controlled trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 5
- By:
- Publication type:
- Article
26
Omitting axillary dissection in breast cancer with sentinel-node metastases.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 4
- By:
- Publication type:
- Article
27
Aspirin vs placebo as adjuvant therapy for breast cancer: The Alliance A011502 randomized trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 4
- By:
- Publication type:
- Article
28
Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: Eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 3
- By:
- Publication type:
- Article
29
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 3
- By:
- Publication type:
- Article
30
Adjuvant abemaciclib plus endocrine therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative, high-risk early breast cancer: Results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 3
- By:
- Publication type:
- Article
31
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802).
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 2
- By:
- Publication type:
- Article
32
Tumor-infiltrating lymphocytes in triple-negative breast cancer.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 1
- By:
- Publication type:
- Article
33
Welcome to Issue 43 of Breast Cancer Research Review.
- Published in:
- Breast Cancer Research Review, 2024, n. 43, p. 1
- By:
- Publication type:
- Article
34
Understanding patient preferences regarding the important determinants of breast cancer treatment: A narrative scoping review.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 6
- By:
- Publication type:
- Article
35
Key factors in the decision-making process for mastectomy alone or breast reconstruction: A qualitative analysis.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 6
- By:
- Publication type:
- Article
36
Ten-year follow-up of women at high risk for familial breast and ovarian cancer in Otago and Southland, New Zealand.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 5
- By:
- Publication type:
- Article
37
Analysis of breast cancer mortality in the US-1975 to 2019.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 5
- By:
- Publication type:
- Article
38
Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 5
- By:
- Publication type:
- Article
39
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): A randomised, open-label, multicentre, phase 3 trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 4
- By:
- Publication type:
- Article
40
Third-line treatment for metastatic triplenegative breast cancer: A systematic review and network meta-analysis.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 4
- By:
- Publication type:
- Article
41
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: Results from the NeoSTAR trial.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 3
- By:
- Publication type:
- Article
42
Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): Primary results of a prospective two-arm study.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 2
- By:
- Publication type:
- Article
43
Pregnancy after breast cancer in young BRCA carriers: An international hospital-based cohort study.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 1
- By:
- Publication type:
- Article
44
Welcome to Issue 42 of Breast Cancer Research Review.
- Published in:
- Breast Cancer Research Review, 2024, n. 42, p. 1
- By:
- Publication type:
- Article